News PathoQuest Appoints Sébastien Renouf, Pharm D., as Chief Pharmaceutical Officer Dr. Sébastien Renouf has almost 20 years of experience in Regulatory Affairs, Risk Management, Quality Assurance, and Safety Control for Cell & Gene Therapy. Before joining...
Interview with Colette Côté, Ph.D. : Chief Portfolio Officer and General Manager of PathoQuest’s U.S. subsidiary located in Wayne, PA. Return to the news page PathoQuest is a pioneer in the development and application of novel Next Generation Sequencing (NGS)-based...
Preferred Events 4th Annual NGS Seminar – 2021 Digital Edition 14 September, 2021 16:00-19:00 CST | 10:00 AM-01:00 PM EST | 07:00-10:00 AM PST The impact of COVID-19 has highlighted the biopharmaceutical industry’s need for fast & innovative solutions...
News Meet Olivier Matteudi our new NGS specialist! PathoQuest is glad to introduce, Olivier Matteudi as our new NGS sales application specialist. With over 30 years of experience in the genomic field, he will bring his strong NGS expertise to the Biologics Genomic...
World Health Day | 7 Apr., 2021 Return to the news page PathoQuest fully supports the #worldhealthday and works every day to improve the care of patients by accelerating access to innovative medicines Building a fairer, healthier world | Learn...
Press Release PathoQuest Appoints Eric Cazergue as Chief Financial Officer Pour la version en français de ce communiqué de presse : cliquez ici PARIS, FRANCE — April 06, 2021 – PathoQuest, a pioneer of Next Generation Sequencing (NGS)-based testing solutions for...